OPKO Health Inc. (OPK): Price and Financial Metrics


OPKO Health Inc. (OPK): $1.87

0.01 (+0.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OPK POWR Grades

  • Stability is the dimension where OPK ranks best; there it ranks ahead of 51.69% of US stocks.
  • The strongest trend for OPK is in Momentum, which has been heading up over the past 177 days.
  • OPK's current lowest rank is in the Growth metric (where it is better than 6.55% of US stocks).

OPK Stock Summary

  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.4 for OPKO HEALTH INC; that's greater than it is for just 21.87% of US stocks.
  • Over the past twelve months, OPK has reported earnings growth of -270.37%, putting it ahead of just 6.38% of US stocks in our set.
  • As for revenue growth, note that OPK's revenue has grown -25.34% over the past 12 months; that beats the revenue growth of only 7.02% of US companies in our set.
  • Stocks that are quantitatively similar to OPK, based on their financial statements, market capitalization, and price volatility, are PLPC, OFIX, BSQR, HUN, and BRC.
  • Visit OPK's SEC page to see the company's official filings. To visit the company's web site, go to www.opko.com.

OPK Valuation Summary

  • OPK's EV/EBIT ratio is -8.2; this is 202.5% lower than that of the median Healthcare stock.
  • Over the past 243 months, OPK's price/sales ratio has gone down 15.

Below are key valuation metrics over time for OPK.

Stock Date P/S P/B P/E EV/EBIT
OPK 2022-09-23 1.0 0.8 -7.2 -8.2
OPK 2022-09-22 1.0 0.8 -7.2 -8.3
OPK 2022-09-21 1.0 0.9 -7.3 -8.3
OPK 2022-09-20 1.1 0.9 -7.4 -8.5
OPK 2022-09-19 1.1 0.9 -7.5 -8.6
OPK 2022-09-16 1.1 0.9 -7.8 -9.0

OPK Growth Metrics

    Its 5 year revenue growth rate is now at -27.11%.
  • The 3 year price growth rate now stands at 16.75%.
  • Its 3 year revenue growth rate is now at 62.74%.
Over the past 33 months, OPK's revenue has gone up $526,811,000.

The table below shows OPK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 1,426.256 -3.58 -202.118
2022-03-31 1,558.771 -7.556 -116.654
2021-12-31 1,774.718 38.337 -30.143
2021-09-30 1,868.06 78.238 75.929
2021-06-30 1,910.311 107.853 70.907
2021-03-31 1,769.11 108.883 120.796

OPK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OPK has a Quality Grade of C, ranking ahead of 62.7% of graded US stocks.
  • OPK's asset turnover comes in at 0.76 -- ranking 36th of 682 Pharmaceutical Products stocks.
  • LFVN, GBT, and SYRS are the stocks whose asset turnover ratios are most correlated with OPK.

The table below shows OPK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.760 0.347 0.102
2021-06-30 0.781 0.347 0.094
2021-03-31 0.730 0.368 0.140
2020-12-31 0.611 0.377 0.063
2020-09-30 0.505 0.384 -0.079
2020-06-30 0.418 0.392 -0.157

OPK Price Target

For more insight on analysts targets of OPK, see our OPK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.60 Average Broker Recommendation 1.2 (Strong Buy)

OPK Stock Price Chart Interactive Chart >

Price chart for OPK

OPK Price/Volume Stats

Current price $1.87 52-week high $5.25
Prev. close $1.86 52-week low $1.78
Day low $1.87 Volume 11,987
Day high $1.87 Avg. volume 4,218,465
50-day MA $2.30 Dividend yield N/A
200-day MA $3.05 Market Cap 1.44B

OPKO Health Inc. (OPK) Company Bio


OPKO Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies. The company was founded in 2005 and is based in Miami, Florida.


OPK Latest News Stream


Event/Time News Detail
Loading, please wait...

OPK Latest Social Stream


Loading social stream, please wait...

View Full OPK Social Stream

Latest OPK News From Around the Web

Below are the latest news stories about OPKO HEALTH INC that investors may wish to consider to help them evaluate OPK as an investment opportunity.

Jon Cohen and Michael Hansen Join Talkspace’s Board of Directors

Shareholders Approve All Measures at First Annual Meeting of StockholdersNEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Shareholders of Talkspace, Inc. (Nasdaq: TALK) today elected Jon Cohen, M.D., to the virtual behavioral healthcare company’s board of directors and approved all other shareholder proposals during the company’s first Annual Meeting of Stockholders. Dr. Cohen is prior Executive Chairman and Chief Executive Officer of BioReference Laboratories and Senior Vice President of OPKO Healt

Yahoo | September 15, 2022

Investors five-year losses grow to 65% as the stock sheds US$139m this past week

We think intelligent long term investing is the way to go. But unfortunately, some companies simply don't succeed. For...

Yahoo | September 5, 2022

10 Best Stocks to Buy According to Yale Finance Professor

In this article, we will be taking a look at the top 10 stocks to buy according to Roger Ibbotson’s Zebra Capital. To skip our detailed analysis, you can go directly to see 5 Stocks to Buy According to Roger Ibbotson’s Zebra Capital. Ibbotson’s top 10 stock picks lost 9.5% since the end of the first […]

Yahoo | August 31, 2022

3 Reasons to Hold OPKO Health (OPK) Stock in Your Portfolio

Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee.

Yahoo | August 23, 2022

Key Opko Health executive retires

Opko Health (Nasdaq: OPK) announced Dr. Jon R. Cohen has retired as executive chairman and CEO of its BioReference Laboratories subsidiary. Cohen also retired from his role as senior VP and director of Miami-based Opko, although he will remain an employed adviser to the company through the end of December, and then be a consultant for another nine months. According to a filing with the U.S. Securities and Exchange Commission, Opko will pay Cohen $1 million in severance, plus the full acceleration and vesting of his stock options.

Yahoo | August 17, 2022

Read More 'OPK' Stories Here

OPK Price Returns

1-mo -18.70%
3-mo -26.09%
6-mo -46.72%
1-year -49.05%
3-year -10.10%
5-year -72.74%
YTD -61.12%
2021 21.77%
2020 168.71%
2019 -51.16%
2018 -38.57%
2017 -47.31%

Continue Researching OPK

Want to see what other sources are saying about Opko Health Inc's financials and stock price? Try the links below:

Opko Health Inc (OPK) Stock Price | Nasdaq
Opko Health Inc (OPK) Stock Quote, History and News - Yahoo Finance
Opko Health Inc (OPK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5508 seconds.